Spiral Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $27.1M

  • Investors
  • 14

Spiral Therapeutics General Information

Description

Developer of drug therapies designed to treat inner ear disorders. The company offers therapies targeting acute and subacute hearing loss and balance conditions, enabling patients to access treatment options for the prevention and management of hearing loss.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6000 Shoreline Court
  • Suite 206
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Vertical(s)
Corporate Office
  • 6000 Shoreline Court
  • Suite 206
  • South San Francisco, CA 94080
  • United States
+1 (650)

Spiral Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spiral Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 14-Apr-2026 $27.1M Completed Startup
4. Secondary Transaction - Private Completed Clinical Trials - Phase 2
3. Later Stage VC (Series A) 07-Feb-2023 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 05-May-2019 $10.2M $13.2M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A2) 31-Dec-2016 $3M $3M Completed Startup
To view Spiral Therapeutics’s complete valuation and funding history, request access »

Spiral Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-3
Series B-2
Series B-1
Series A5
Series A4
Series A3
Series A2 3,080,869 $0.000100 8% $1.03 $1.03 1x $1.03 2.53%
Series A1 2,565,443 $0.000100 8% $2.16 $2.16 1x $2.16 2.11%
To view Spiral Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Spiral Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of drug therapies designed to treat inner ear disorders. The company offers therapies targeting acute and suba
Drug Discovery
South San Francisco, CA
10 As of 2025

Oklahoma City, OK

Tubingen, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Spiral Therapeutics Competitors (8)

One of Spiral Therapeutics’s 8 competitors is Otologic Pharmaceutics, a Formerly VC-backed company based in Oklahoma City, OK.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Otologic Pharmaceutics Formerly VC-backed Oklahoma City, OK
Acousia Therapeutics Venture Capital-Backed Tubingen, Germany
Akouos Formerly VC-backed Boston, MA
Audion Therapeutics Venture Capital-Backed Amsterdam, Netherlands
Sound Pharmaceuticals Venture Capital-Backed Seattle, WA
You’re viewing 5 of 8 competitors. Get the full list »

Spiral Therapeutics Patents

Spiral Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12728245-B2 System for accessing a cochlear implant lead insertion site Active 26-Sep-2024
US-20260097191-A1 System for accessing a cochlear implant lead insertion site Pending 26-Sep-2024
US-20260102594-A1 System for accessing a cochlear implant lead insertion site Active 26-Sep-2024
US-20260102596-A1 System for accessing a cochlear implant lead insertion site Pending 26-Sep-2024
US-20260108714-A1 System for accessing a cochlear implant lead insertion site Pending 26-Sep-2024 A61M39/10
To view Spiral Therapeutics’s complete patent history, request access »

Spiral Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Spiral Therapeutics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advanced Bionics Corporation Minority
Esperante Ventures Corporate Venture Capital Minority
Gund Investment (Mongolia) Limited Partner Minority
Pebble Accelerator Venture Capital Minority
Uni-Bio Science Corporation Minority
You’re viewing 5 of 14 investors. Get the full list »

Spiral Therapeutics Investments (2)

Spiral Therapeutics’s most recent deal was a Corporate Asset Purchase with Otonomy (Certain Assets) for . The deal was made on 29-Mar-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Otonomy (Certain Assets) 29-Mar-2023 Corporate Asset Purchase Buildings and Property
Agatha 03-Nov-2021 Later Stage VC Enterprise Systems (Healthcare)
To view Spiral Therapeutics’s complete investments history, request access »

Spiral Therapeutics FAQs

  • When was Spiral Therapeutics founded?

    Spiral Therapeutics was founded in 2016.

  • Where is Spiral Therapeutics headquartered?

    Spiral Therapeutics is headquartered in South San Francisco, CA.

  • What is the size of Spiral Therapeutics?

    Spiral Therapeutics has 10 total employees.

  • What industry is Spiral Therapeutics in?

    Spiral Therapeutics’s primary industry is Drug Discovery.

  • Is Spiral Therapeutics a private or public company?

    Spiral Therapeutics is a Private company.

  • What is the current valuation of Spiral Therapeutics?

    The current valuation of Spiral Therapeutics is .

  • What is Spiral Therapeutics’s current revenue?

    The current revenue for Spiral Therapeutics is .

  • How much funding has Spiral Therapeutics raised over time?

    Spiral Therapeutics has raised $51.2M.

  • Who are Spiral Therapeutics’s investors?

    Advanced Bionics, Esperante Ventures, Gund Investment (Mongolia), Pebble Accelerator, and Uni-Bio Science are 5 of 14 investors who have invested in Spiral Therapeutics.

  • Who are Spiral Therapeutics’s competitors?

    Otologic Pharmaceutics, Acousia Therapeutics, Akouos, Audion Therapeutics, and Sound Pharmaceuticals are some of the 8 competitors of Spiral Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process